🇺🇸 FDA
Patent

US 6596762

Antioxidant compositions and use for treatment of hepatic steatosis and steatohepatitis

expired A61KA61K31/015A61K31/07

Quick answer

US patent 6596762 (Antioxidant compositions and use for treatment of hepatic steatosis and steatohepatitis) held by The Regents of the University of Colorado expires Mon Jul 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of Colorado
Grant date
Tue Jul 22 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K31/015, A61K31/07, A61K31/355, A61K33/04